Endece Llc Headquarters

The links below provide all the necessary information about Endece Llc Headquarters. Also there you will find information about the address, phone numbers, emails and much more.

Contact - ENDECE

https://endece.com/contact/

ENDECE developed lead drug NDC-1308 with a dual Mechanism of Action (MOA) providing an anti-inflammatory environment and induces remyelination within the Central Nervous System, treating deadly diseases like Niemann-Pick disease type C, Neuromyelitis Optica Spectrum Disorder (NMOSD), Multiple Sclerosis (MS), and Alzheimer’s Disease

ENDECE NDC-1308 a novel therapeutic for ARDS and …

https://endece.com/

Acute Respiratory Distress Syndrome (ARDS) is a life-threatening condition resulting in a reduction of oxygen that reaches the blood stream and vital organs. Few effective therapeutic modalities exist to treat ARDS, leading to a high …

ENDECE, LLC - WEDC

https://wedc.org/entrepreneurs/innovation-investment-portfolio/endece-llc/

INVESTMENTS IN INNOVATION TDL ENDECE, LLC Biosciences/Medical Devices 1001 W. Glen Oaks Lane, Suite 105B Mequon, 53092United States www.endece.com ENDECE is focused on discovery and development of new drug therapies to stop or reverse disease progression by controlling key cellular pathways. ENDECE focuses on diseases whose treatment options are …

ENDECE, LLC - Think-Make-Happen In Wisconsin

https://inwisconsin.com/entrepreneurs/innovation-investment-portfolio/endece-llc/

ENDECE, LLC. Biosciences/Medical Devices. 1001 W. Glen Oaks Lane, Suite 105B. Mequon, 53092. United States. www.endece.com. ENDECE is focused on discovery and development of new drug therapies to stop or reverse disease progression by controlling key cellular pathways. ENDECE focuses on diseases whose treatment options are limited or non ...

ENDECE - LinkedIn

https://www.linkedin.com/company/endece-llc

Kashiv BioSciences LLC ... ENDECE designed NDC-1308 to reduce the ability of SARS-CoV-2 / COVID-19 to replicate within the pulmonary system, and reduce inflammation. ...

The ENDECE Management Team of experienced …

https://endece.com/about/management-team/

Jean Yarger. Jean Yarger co-founded and serves as Administrative Officer for ENDECE. Her multidisciplinary background and experience includes finance, human resources, document management, project management and establishing corporate structures that facilitate and support scientific research and development. Jean is a serial entrepreneur.

ENDECE Opens San Francisco Office - Business Wire

https://www.businesswire.com/news/home/20170213005244/en/ENDECE-Opens-San-Francisco-Office

[email protected]

ENDECE Intellectual Property, ENDECE Patents, ENDECE …

https://endece.com/about/endece-intellectual-property/

ENDECE cautions readers to not unduly rely on any estimates, projections or other forward-looking statements or data contained herein to reach conclusions or make any decision regarding the document. As such, nothing in this document is, or may be relied upon as, a promise or representation by ENDECE as to the past or the future.

Endece, LLC - Better Business Bureau

https://www.bbb.org/us/wi/mequon/profile/laboratory-research/endece-llc-0694-44262077

Business Profile. Endece, LLC. 1001 W Glen Oaks Ln Ste 105B. Mequon, WI 53092-3366. (262) 240-9690. At-a-glance.

CEO, Board, Board Advisor Recruiting - DOMANN

https://domann.net/portfolio/the-seasoned-and-steady-hand-of-tenured-leadership/

ENDECE, LLC (ENDECE), founded in 2006, is a privately held biopharmaceutical drug discovery and development company (www.endece.com) based in Wisconsin. The company focuses on small molecule compounds that control key genes within specific signaling pathways as a platform for discovering drugs capable of treating diseases for which there are no ...

ENDECE - Facebook

https://www.facebook.com/NDC1308/

ENDECE developed NDC-1308 a novel therapeutic for COVID-19, reducing inflammation as well as the... 1001 W. Glen Oaks Lane, Suite 105B, Mequon, WI 53092

News Archives - ENDECE

https://endece.com/category/news/

NDC-1308 (MC1) Therapeutic for Seasonal Viral Influenza. by Endece | Jul 9, 2020. Within the US alone, there are over 200,000 hospitalizations annually from seasonal viral influenza. Patients requiring mechanical ventilation have a high mortality rate of 20% or over 40,000 people annually.The World Health Organization (WHO) estimates that ...

Endec Inc - Bloomberg.com

https://www.bloomberg.com/profile/company/0028277D:PM

Company profile page for Endec Inc including stock price, company news, press releases, executives, board members, and contact information

Enesco, LLC – Enesco Corporate Website

https://enesco.com/